Foreign media: The biotechnology industry in China is on the rise, especially its drug development capabilities have drawn global attention.
A little-known biotechnology company in Guangzhou, China, has developed an anti-cancer drug called ivonescimab, which has shown excellent performance in clinical trials, delaying the progression of non-small cell lung cancer more effectively than the globally popular drug Keytruda, attracting investor attention and being dubbed by Western media as the "DeepSeek moment" of China's pharmaceutical industry.
However, despite progress in drug development, experts and analysts question whether China can sustain similar successes like ivonescimab, especially in complex and highly regulated fields, where achieving innovative breakthroughs is more difficult.
Original article: www.toutiao.com/article/1845036700140620/
Statement: This article represents the views of the author.